MSH2 and neoplasm: In one of these studies, a higher frequency of MSI and an earlier mean age of onset of cancer were found in carriers of the MSH2 gene mutation than in carriers of mutations in other MMR genes, suggesting that an MSH2 mutation may indicate a faster rate of tumor progression [54].